SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-204056
Filing Date
2019-07-26
Accepted
2019-07-26 16:40:18
Documents
1
Group Members
FHMLS IX, L.L.C.FHMLS IX, L.P.JAMES TOPPERPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d785138dsc13d.htm SC 13D 137430
  Complete submission text file 0001193125-19-204056.txt   139044
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences IX, L.P. (Filed by) CIK: 0001720320 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91075 | Film No.: 19978421
SIC: 2834 Pharmaceutical Preparations